Corbus Pharmaceuticals Holdings, Inc. CRBP Stock Forecast
AI-powered price prediction and analysis for Corbus Pharmaceuticals Holdings, Inc. ยท Updated Mar 31, 2026
See CRBP's Exact Price Target
Create a free account to unlock AI predictions for 4,000+ stocks
Sign Up Free with GooglePrice Chart
Key Statistics
About Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) operates in the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. The company employs approximately 52 people.
We do not have any company description for Corbus Pharmaceuticals Holdings, Inc. at the moment.
Latest News
- Why Corbus Pharmaceuticals Holdings Inc. Tumbled Today
- Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day
- Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains
- Sign up free to read all 11 articles โ
Pharmaceutical Preparations Peers
| Company | Ticker | AI Signal | Market Cap | P/E |
|---|---|---|---|---|
| Aardvark Therapeutics, Inc. | AARD | โโ% | $88M | -x |
| Abbvie Inc. | ABBV | โโ% | $379.29B | 89.8x |
| Abcellera Biologics Inc. | ABCL | โโ% | $1.07B | -5.3x |
| Abeona Therapeutics Inc. | ABEO | โโ% | $250M | 3.5x |
| Abbott Laboratories | ABT | โโ% | $180.40B | 27.7x |
| Arbutus Biopharma Corp | ABUS | โโ% | $865M | -8.3x |
| Abvc Biopharma, Inc. | ABVC | โโ% | $26M | -0.3x |
| Abivax S.A. | ABVX | โโ% | $9.07B | -x |
| Acadia Pharmaceuticals Inc | ACAD | โโ% | $3.78B | 9.7x |
| Adicet Bio, Inc. | ACET | โโ% | $66M | -0.4x |
| Aclaris Therapeutics, Inc. | ACRS | โโ% | $485M | -4.5x |
| Acrivon Therapeutics, Inc. | ACRV | โโ% | $57M | -2.8x |
| Actuate Therapeutics, Inc. | ACTU | โโ% | $120M | -x |
| Accustem Sciences Inc. | ACUT | โโ% | $6M | -x |
| Acurx Pharmaceuticals, Inc. | ACXP | โโ% | $11M | -0.8x |
| Adagene Inc. | ADAG | โโ% | $210M | -x |
| Adc Therapeutics Sa | ADCT | โโ% | $478M | -9.2x |
| Adial Pharmaceuticals, Inc. | ADIL | โโ% | $3M | -0.1x |
| Aditxt, Inc. | ADTX | โโ% | $450K | 0.0x |
| Addex Therapeutics Ltd. | ADXN | โโ% | $8M | -x |
| Aeon Biopharma, Inc. | AEON | โโ% | $25M | 6.4x |
| Agios Pharmaceuticals, Inc. | AGIO | โโ% | $1.99B | 3.7x |
| Ainos, Inc. | AIMD | โโ% | $8M | -0.4x |
| Akebia Therapeutics, Inc. | AKBA | โโ% | $376M | -5.4x |
| Akero Therapeutics, Inc. | AKRO | โโ% | $4.38B | -8.7x |
| Akari Therapeutics Plc | AKTX | โโ% | $6M | -2.0x |
| Aldeyra Therapeutics, Inc. | ALDX | โโ% | $104M | -5.1x |
| Alkermes Plc. | ALKS | โโ% | $5.70B | 23.6x |
| Allarity Therapeutics, Inc. | ALLR | โโ% | $18M | -0.2x |
| Alumis Inc. | ALMS | โโ% | $2.94B | -x |
| Alnylam Pharmaceuticals, Inc. | ALNY | โโ% | $43.65B | 139.1x |
| Altimmune, Inc. | ALT | โโ% | $405M | -5.7x |
| Alx Oncology Holdings โฆ | ALXO | โโ% | $259M | -0.4x |
| Alzamend Neuro, Inc. | ALZN | โโ% | $4M | -0.1x |
| Amylyx Pharmaceuticals, Inc. | AMLX | โโ% | $1.56B | -1.5x |
| Amphastar Pharmaceuticals, Inc. | AMPH | โโ% | $921M | 9.4x |
| Amarin Corp Plc\Uk | AMRN | โโ% | $302M | -4.5x |
| Amneal Pharmaceuticals, Inc. | AMRX | โโ% | $3.95B | 54.8x |
| Anaptysbio, Inc | ANAB | โโ% | $1.57B | -2.5x |
| Anebulo Pharmaceuticals, Inc. | ANEB | โโ% | $41M | -4.3x |
| Ani Pharmaceuticals Inc | ANIP | โโ% | $1.71B | 21.8x |
| Anixa Biosciences Inc | ANIX | โโ% | $90M | -15.0x |
| Annexon, Inc. | ANNX | โโ% | $806M | -4.1x |
| Alto Neuroscience, Inc. | ANRO | โโ% | $744M | -x |
| An2 Therapeutics, Inc. | ANTX | โโ% | $125M | -x |
| Annovis Bio, Inc. | ANVS | โโ% | $57M | -1.0x |
| Apollomics Inc. | APLM | โโ% | $32M | -x |
| Apellis Pharmaceuticals, Inc. | APLS | โโ% | $5.11B | 228.4x |
| Applied Therapeutics, Inc. | APLT | โโ% | $15M | -0.7x |
| Aprea Therapeutics, Inc. | APRE | โโ% | $8M | -1.2x |
| Apimeds Pharmaceuticals Us, โฆ | APUS | โโ% | $22M | -x |
| Aptevo Therapeutics Inc. | APVO | โโ% | $6M | -0.1x |
| Aquestive Therapeutics, Inc. | AQST | โโ% | $501M | -10.7x |
| Arcturus Therapeutics Holdings โฆ | ARCT | โโ% | $223M | -7.0x |
| Ardelyx, Inc. | ARDX | โโ% | $1.48B | -21.3x |
| Arcutis Biotherapeutics, Inc. | ARQT | โโ% | $2.96B | -6.6x |
| Artelo Biosciences, Inc. | ARTL | โโ% | $6M | -0.7x |
| Arvinas, Inc. | ARVN | โโ% | $705M | -4.8x |
| Arrowhead Pharmaceuticals, Inc. | ARWR | โโ% | $8.70B | 43.0x |
| Aspire Biopharma Holdings, โฆ | ASBP | โโ% | $5M | -x |
| Assembly Biosciences, Inc. | ASMB | โโ% | $461M | -1.5x |
| Ascendis Pharma A/S | ASND | โโ% | $14.18B | -x |
| Assertio Holdings, Inc. | ASRT | โโ% | $117M | -0.2x |
| Atai Beckley N.V. | ATAI | โโ% | $1.23B | -4.4x |
| Alterity Therapeutics Ltd | ATHE | โโ% | $68M | -x |
| Actinium Pharmaceuticals, Inc. | ATNM | โโ% | $31M | -4.1x |
| Atossa Therapeutics, Inc. | ATOS | โโ% | $41M | -6.2x |
| Avenue Therapeutics, Inc. | ATXI | โโ% | $920K | -9.5x |
| Astria Therapeutics, Inc. | ATXS | โโ% | $710M | -4.7x |
| Aurinia Pharmaceuticals Inc. | AUPH | โโ% | $1.85B | 6.4x |
| Arrivent Biopharma, Inc. | AVBP | โโ% | $892M | -x |
| Avadel Pharmaceuticals Plc | AVDL | โโ% | $2.10B | -10.2x |
| Atea Pharmaceuticals, Inc. | AVIR | โโ% | $397M | -1.5x |
| Avalo Therapeutics, Inc. | AVTX | โโ% | $317M | -0.1x |
| Axim Biotechnologies, Inc. | AXIM | โโ% | $2M | -x |
| Axsome Therapeutics, Inc. | AXSM | โโ% | $8.17B | -19.9x |
| Aytu Biopharma, Inc | AYTU | โโ% | $27M | -0.3x |
| Azitra, Inc. | AZTR | โโ% | $4M | -0.2x |
| Bridgebio Pharma, Inc. | BBIO | โโ% | $14.46B | -11.6x |
| Bicara Therapeutics Inc. | BCAX | โโ% | $1.23B | -x |
| Briacell Therapeutics Corp. | BCTX | โโ% | $30M | -1.7x |
| Bicycle Therapeutics Plc | BCYC | โโ% | $301M | -6.0x |
| Bioadaptives, Inc. | BDPT | โโ% | $130K | -x |
| Biodexa Pharmaceuticals Plc | BDRX | โโ% | $510K | -x |
| Beone Medicines Ltd. | BEIGF | โโ% | $36.38B | 530.6x |
| Bullfrog Ai Holdings, โฆ | BFRG | โโ% | $12M | -2.9x |
| Biofrontera Inc. | BFRI | โโ% | $9M | -0.1x |
| Bausch Health Companies โฆ | BHC | โโ% | $2.00B | 12.7x |
| Bioharvest Sciences Inc. | BHST | โโ% | $97M | -x |
| Biohaven Ltd. | BHVN | โโ% | $1.22B | -4.6x |
| Bioage Labs, Inc. | BIOA | โโ% | $782M | -x |
| Bio Essence Corp | BIOE | โโ% | $6M | 7.2x |
| Biovie Inc. | BIVI | โโ% | $10M | -0.6x |
| Bioxytran, Inc | BIXT | โโ% | $3M | -x |
| Biolinerx Ltd. | BLRX | โโ% | $12M | -x |
| Belite Bio, Inc | BLTE | โโ% | $6.27B | -x |
| Biomea Fusion, Inc. | BMEA | โโ% | $95M | -1.6x |
| Biomarin Pharmaceutical Inc | BMRN | โโ% | $10.54B | 30.2x |
| Bristol Myers Squibb โฆ | BMY | โโ% | $121.49B | 17.2x |
| Bristol Myers Squibb โฆ | BMYMP | โโ% | $1.73T | 287.0x |
| Benitec Biopharma Inc. | BNTC | โโ% | $345M | -0.6x |
| Boundless Bio, Inc. | BOLD | โโ% | $25M | -15.1x |
| Bolt Biotherapeutics, Inc. | BOLT | โโ% | $8M | -0.3x |
| Bio-Path Holdings, Inc. | BPTH | โโ% | $530K | 0.0x |
| Bioquest Corp | BQST | โโ% | $14M | -x |
| Barinthus Biotherapeutics Plc. | BRNS | โโ% | $22M | -0.6x |
| Bespoke Extracts, Inc. | BSPK | โโ% | $2M | -x |
| Bioxcel Therapeutics, Inc. | BTAI | โโ% | $27M | -0.1x |
| Beyondspring Inc. | BYSI | โโ% | $72M | 63.8x |
| Calcimedica, Inc. | CALC | โโ% | $8M | 0.4x |
| Camp4 Therapeutics Corp | CAMP | โโ% | $208M | -0.1x |
| Can-Fite Biopharma Ltd. | CANF | โโ% | $7M | -x |
| Capricor Therapeutics, Inc. | CAPR | โโ% | $1.74B | -x |
| Carisma Therapeutics Inc. | CARM | โโ% | $1M | 0.2x |
| Casi Pharmaceuticals, Inc. | CASI | โโ% | $5M | -1.4x |
| Perspective Therapeutics, Inc. | CATX | โโ% | $436M | -2.8x |
| Crescent Biopharma, Inc. | CBIO | โโ% | $458M | -6.5x |
| Cdt Equity Inc. | CDT | โโ% | $2M | -0.7x |
| Cingulate Inc. | CING | โโ% | $78M | -0.6x |
| Cell Source, Inc. | CLCS | โโ% | $33M | -x |
| Clene Inc. | CLNN | โโ% | $52M | -7.3x |
| Cellectar Biosciences, Inc. | CLRB | โโ% | $11M | -x |
| Clearside Biomedical, Inc. | CLSD | โโ% | $4M | -2.0x |
| Climb Bio, Inc. | CLYM | โโ% | $446M | -1.4x |
| Chemomab Therapeutics Ltd. | CMMB | โโ% | $10M | 10.9x |
| Clearmind Medicine Inc. | CMND | โโ% | $2M | -x |
| Compass Pathways Plc | CMPS | โโ% | $713M | 0.0x |
| Cnbx Pharmaceuticals Inc. | CNBX | โโ% | $90K | -x |
| Cns Pharmaceuticals, Inc. | CNSP | โโ% | $2M | 0.0x |
| Centessa Pharmaceuticals Plc | CNTA | โโ% | $5.93B | -11.0x |
| Connect Biopharma Holdings โฆ | CNTB | โโ% | $162M | -x |
| Context Therapeutics Inc. | CNTX | โโ% | $241M | -1.5x |
| Cocrystal Pharma, Inc. | COCP | โโ% | $13M | -1.0x |
| Cogent Biosciences, Inc. | COGT | โโ% | $5.63B | -3.7x |
| Collegium Pharmaceutical, Inc | COLL | โโ% | $1.01B | 16.1x |
| Corcept Therapeutics Inc | CORT | โโ% | $3.58B | 36.0x |
| Coya Therapeutics, Inc. | COYA | โโ% | $98M | -6.8x |
| China Pharma Holdings, โฆ | CPHI | โโ% | $3M | -0.2x |
| Cumberland Pharmaceuticals Inc | CPIX | โโ% | $47M | -4.5x |
| Cannapharmarx, Inc. | CPMD | โโ% | $3M | -x |
| Catalyst Pharmaceuticals, Inc. | CPRX | โโ% | $2.91B | 13.6x |
| Corbus Pharmaceuticals Holdings, โฆ | CRBP | โโ% | $151M | -2.0x |
| Cormedix Inc. | CRMD | โโ% | $521M | 3.2x |
| Crinetics Pharmaceuticals, Inc. | CRNX | โโ% | $3.28B | -15.9x |
| Cervomed Inc. | CRVO | โโ% | $36M | -0.7x |
| Corvus Pharmaceuticals, Inc. | CRVS | โโ% | $1.13B | -13.7x |
| Cytomx Therapeutics, Inc. | CTMX | โโ% | $953M | 29.5x |
| Contineum Therapeutics, Inc. | CTNM | โโ% | $460M | -x |
| Citius Oncology, Inc. | CTOR | โโ% | $53M | 3.9x |
| Hepion Pharmaceuticals, Inc. | CTRVP | โโ% | $20K | -x |
| Citius Pharmaceuticals, Inc. | CTXR | โโ% | $15M | -5.3x |
| Cue Biopharma, Inc. | CUE | โโ% | $25M | -1.2x |
| Cadrenal Therapeutics, Inc. | CVKD | โโ% | $10M | -11.1x |
| Cv Sciences, Inc. | CVSI | โโ% | $6M | -x |
| Cyclerion Therapeutics, Inc. | CYCN | โโ% | $6M | -5.2x |
| Cytodyn Inc. | CYDY | โโ% | $342M | 86.7x |
| Cryoport, Inc. | CYRX | โโ% | $413M | 5.3x |
| Cytokinetics Inc | CYTK | โโ% | $7.76B | -9.4x |
| Dare Bioscience, Inc. | DARE | โโ% | $26M | 2.9x |
| Day One Biopharmaceuticals, โฆ | DAWN | โโ% | $2.21B | -8.9x |
| Journey Medical Corp | DERM | โโ% | $156M | 24.1x |
| Diamedica Therapeutics Inc. | DMAC | โโ% | $357M | -4.2x |
| Dianthus Therapeutics, Inc. โฆ | DNTH | โโ% | $4.16B | -3.2x |
| Dermata Therapeutics, Inc. | DRMA | โโ% | $4M | -0.2x |
| Bright Minds Biosciences โฆ | DRUG | โโ% | $670M | -x |
| Design Therapeutics, Inc. | DSGN | โโ% | $643M | -7.6x |
| Dynavax Technologies Corp | DVAX | โโ% | $1.82B | 88.2x |
| Dogwood Therapeutics, Inc. | DWTX | โโ% | $86M | -2.9x |
| Dyne Therapeutics, Inc. | DYN | โโ% | $2.82B | -7.8x |
| Emergent Biosolutions Inc. | EBS | โโ% | $419M | 8.0x |
| Edesa Biotech, Inc. | EDSA | โโ% | $44M | -1.3x |
| Eagle Pharmaceuticals, Inc. | EGRX | โโ% | $4M | 0.4x |
| Pmgc Holdings Inc. | ELAB | โโ% | $2M | -8.2x |
| Elanco Animal Health โฆ | ELAN | โโ% | $12.34B | 341.6x |
| Eledon Pharmaceuticals, Inc. | ELDN | โโ% | $239M | -x |
| Elite Pharmaceuticals Inc โฆ | ELTP | โโ% | $387M | 14.7x |
| Elicio Therapeutics, Inc. | ELTX | โโ% | $179M | -1.9x |
| Enliven Therapeutics, Inc. | ELVN | โโ% | $1.85B | -13.3x |
| Emmaus Life Sciences, โฆ | EMMA | โโ% | $980K | -x |
| Enlivex Ltd. | ENLV | โโ% | $261M | -x |
| Ensysce Biosciences, Inc. | ENSC | โโ% | $2M | -x |
| Enanta Pharmaceuticals Inc | ENTA | โโ% | $351M | -1.3x |
| Gridai Technologies Corp. | ENTO | โโ% | $7M | 0.0x |
| Enveric Biosciences, Inc. | ENVB | โโ% | $3M | -0.1x |
| Evolus, Inc. | EOLS | โโ% | $314M | -13.1x |
| Essa Pharma Inc. | EPIX | โโ% | $9M | -2.7x |
| Eupraxia Pharmaceuticals Inc. | EPRX | โโ% | $407M | -x |
| Equillium, Inc. | EQ | โโ% | $108M | -3.2x |
| Erasca, Inc. | ERAS | โโ% | $4.17B | -3.1x |
| Ernexa Therapeutics Inc. | ERNA | โโ% | $6M | -x |
| Esperion Therapeutics, Inc. | ESPR | โโ% | $704M | -4.2x |
| 89bio, Inc. | ETNB | โโ% | $2.20B | -3.5x |
| Eton Pharmaceuticals, Inc. | ETON | โโ% | $621M | -66.2x |
| Earth Science Tech, โฆ | ETST | โโ% | $29M | 14.0x |
| Evofem Biosciences, Inc. | EVFM | โโ% | $1M | 2.9x |
| Edgewise Therapeutics, Inc. | EWTX | โโ% | $3.22B | -19.7x |
| Fuss Brands Corp. | FBDS | โโ% | $2M | -x |
| Fortress Biotech, Inc. | FBIO | โโ% | $88M | 12.8x |
| Fortress Biotech, Inc. | FBIOP | โโ% | $394M | 98.8x |
| Fibrobiologics, Inc. | FBLG | โโ% | $8M | -x |
| Forte Biosciences, Inc. | FBRX | โโ% | $311M | -11.5x |
| Fibrogen Inc | FGEN | โโ% | $35M | 0.2x |
| Foghorn Therapeutics Inc. | FHTX | โโ% | $250M | -3.3x |
| Amicus Therapeutics, Inc. | FOLD | โโ% | $4.48B | -8.5x |
| Fulcrum Therapeutics, Inc. | FULC | โโ% | $438M | -36.1x |
| Galectin Therapeutics Inc | GALT | โโ% | $182M | -2.4x |
| Gain Therapeutics, Inc. | GANX | โโ% | $82M | -1.4x |
| Generation Bio Co. | GBIO | โโ% | $36M | -0.6x |
| Greater Cannabis Company, โฆ | GCAN | โโ% | $230K | -x |
| Geron Corp | GERN | โโ% | $902M | -11.9x |
| Gh Research Plc | GHRS | โโ% | $808M | -x |
| Galmed Pharmaceuticals Ltd. | GLMD | โโ% | $4M | -x |
| Galapagos Nv | GLPG | โโ% | $1.90B | -x |
| Greenwich Lifesciences, Inc. | GLSI | โโ% | $296M | -17.2x |
| Galecto, Inc. | GLTO | โโ% | $1.59B | -2.5x |
| Genelux Corp | GNLX | โโ% | $108M | -2.8x |
| Genprex, Inc. | GNPX | โโ% | $4M | -3.2x |
| Gossamer Bio, Inc. | GOSS | โโ% | $75M | -3.2x |
| Geovax Labs, Inc. | GOVX | โโ% | $3M | -x |
| Structure Therapeutics Inc. | GPCR | โโ% | $3.41B | -44.0x |
| Grace Therapeutics, Inc. | GRCE | โโ% | $72M | -3.9x |
| Gri Bio, Inc. | GRI | โโ% | $4M | -0.1x |
| Galera Therapeutics, Inc. | GRTX | โโ% | $3M | 0.0x |
| Gsk Plc | GSK | โโ% | $104.38B | -x |
| Gt Biopharma, Inc. | GTBP | โโ% | $13M | -x |
| Gyre Therapeutics, Inc. | GYRE | โโ% | $636M | 64.4x |
| Hutchmed (China) Ltd | HCM | โโ% | $2.58B | -x |
| Hcw Biologics Inc. | HCWB | โโ% | $2M | -x |
| Hepion Pharmaceuticals, Inc. | HEPA | โโ% | $640K | -0.1x |
| Hutchmed (China) Ltd | HMDCF | โโ% | $2.64B | -x |
| Hookipa Pharma Inc. | HOOK | โโ% | $13M | -1.0x |
| Hoth Therapeutics, Inc. | HOTH | โโ% | $12M | -0.5x |
| Werewolf Therapeutics, Inc. | HOWL | โโ% | $39M | -1.3x |
| Harmony Biosciences Holdings, โฆ | HRMY | โโ% | $1.55B | 9.8x |
| Heron Therapeutics, Inc. โฆ | HRTX | โโ% | $151M | -6.4x |
| Hst Global, Inc. | HSTC | โโ% | $44M | -x |
| Tuhura Biosciences, Inc./Nv | HURA | โโ% | $89M | -x |
| Ibio, Inc. | IBIO | โโ% | $66M | -0.4x |
| Impact Biomedical Inc. | IBO | โโ% | $65M | -x |
| Ideaya Biosciences, Inc. | IDYA | โโ% | $2.76B | -12.2x |
| Inflarx N.V. | IFRX | โโ% | $60M | -x |
| Igc Pharma, Inc. | IGC | โโ% | $24M | -4.6x |
| Immutep Ltd | IMMP | โโ% | $52M | -x |
| Immix Biopharma, Inc. | IMMX | โโ% | $454M | -x |
| Immunome Inc. | IMNM | โโ% | $2.29B | -2.4x |
| Imunon, Inc. | IMNN | โโ% | $10M | -0.5x |
| Immuron Ltd | IMRN | โโ% | $8M | -x |
| Immuneering Corp | IMRX | โโ% | $341M | -0.8x |
| Eom Pharmaceutical Holdings, โฆ | IMUC | โโ% | $6M | -x |
| Immunic, Inc. | IMUX | โโ% | $145M | -0.8x |
| Integrated Biopharma Inc | INBP | โโ% | $8M | 14.8x |
| Indaptus Therapeutics, Inc. | INDP | โโ% | $4M | -0.6x |
| Indivior Pharmaceuticals, Inc. | INDV | โโ% | $3.60B | 17.1x |
| Inmed Pharmaceuticals Inc. | INM | โโ% | $2M | -51.8x |
| Inovio Pharmaceuticals, Inc. | INO | โโ% | $115M | -0.6x |
| Insmed Inc | INSM | โโ% | $32.85B | -14.0x |
| Inhibitor Therapeutics, Inc. | INTI | โโ% | $21M | -x |
| Innoviva, Inc. | INVA | โโ% | $1.70B | 6.3x |
| Io Biotech, Inc. | IOBT | โโ% | $13M | -0.7x |
| Ionis Pharmaceuticals Inc | IONS | โโ% | $11.38B | -14.6x |
| Opus Genetics, Inc. | IRD | โโ% | $315M | -2.0x |
| Disc Medicine, Inc. | IRON | โโ% | $2.30B | -18.4x |
| Ironwood Pharmaceuticals Inc | IRWD | โโ% | $496M | 20.6x |
| International Stem Cell โฆ | ISCO | โโ% | $1M | -x |
| Iterum Therapeutics Plc | ITRM | โโ% | $4M | -0.8x |
| Inventiva S.A. | IVA | โโ% | $1.25B | -x |
| Incannex Healthcare Inc. | IXHL | โโ% | $42M | -x |
| Jaguar Health, Inc. | JAGX | โโ% | $5M | -0.2x |
| Janux Therapeutics, Inc. | JANX | โโ% | $787M | -63.7x |
| Jazz Pharmaceuticals Plc | JAZZ | โโ% | $11.61B | 14.3x |
| Jade Biosciences, Inc. | JBIO | โโ% | $693M | -x |
| Johnson & Johnson | JNJ | โโ% | $566.39B | 21.1x |
| Jupiter Neurosciences, Inc. | JUNS | โโ% | $11M | -x |
| Kala Bio, Inc. | KALA | โโ% | $156M | -0.5x |
| Kalvista Pharmaceuticals, Inc. | KALV | โโ% | $935M | -2.6x |
| Kairos Pharma, Ltd. | KAPA | โโ% | $11M | -x |
| Kaya Holdings, Inc. | KAYS | โโ% | $23M | -x |
| Kamada Ltd | KMDA | โโ% | $466M | -x |
| Kiniksa Pharmaceuticals International, โฆ | KNSA | โโ% | $3.39B | 57.5x |
| Kiora Pharmaceuticals Inc | KPRX | โโ% | $7M | -2.4x |
| Karyopharm Therapeutics Inc. | KPTI | โโ% | $107M | -0.6x |
| Keros Therapeutics, Inc. | KROS | โโ% | $335M | 3.9x |
| Korro Bio, Inc. | KRRO | โโ% | $148M | -7.9x |
| Pasithea Therapeutics Corp. | KTTA | โโ% | $17M | -73.5x |
| Kura Oncology, Inc. | KURA | โโ% | $709M | -4.5x |
| Kezar Life Sciences, โฆ | KZR | โโ% | $54M | -3.2x |
| Legend Biotech Corp | LEGN | โโ% | $3.43B | -x |
| Lexaria Bioscience Corp. | LEXX | โโ% | $18M | -29.3x |
| Lifecore Biomedical, Inc. โฆ | LFCR | โโ% | $142M | -x |
| Lifevantage Corp | LFVN | โโ% | $56M | 7.2x |
| Ligand Pharmaceuticals Inc | LGND | โโ% | $3.95B | 31.7x |
| Longeveron Inc. | LGVN | โโ% | $27M | -0.5x |
| Lianbio | LIANY | โโ% | $15M | -x |
| Lftd Partners Inc. | LIFD | โโ% | $4M | 56.1x |
| Lipella Pharmaceuticals Inc. | LIPO | โโ% | $730K | -3.3x |
| Lixte Biotechnology Holdings, โฆ | LIXT | โโ% | $26M | -0.9x |
| Lixte Biotechnology Holdings, โฆ | LIXTW | โโ% | $130K | -x |
| Eli Lilly & โฆ | LLY | โโ% | $795.57B | 38.6x |
| Lipocine Inc. | LPCN | โโ% | $43M | -2.6x |
| Cypherpunk Technologies Inc. | LPTX | โโ% | $94M | -1.1x |
| Liquidia Corp | LQDA | โโ% | $3.07B | -7.2x |
| Larimar Therapeutics, Inc. | LRMR | โโ% | $467M | -0.8x |
| Lisata Therapeutics, Inc. | LSTA | โโ% | $44M | -1.0x |
| Lantern Pharma Inc. | LTRN | โโ% | $15M | -2.4x |
| Lava Therapeutics Nv | LVTX | โโ% | $46M | -x |
| Lexicon Pharmaceuticals, Inc. | LXRX | โโ% | $661M | -1.2x |
| Lyell Immunopharma, Inc. | LYEL | โโ% | $410M | -1.1x |
| Maia Biotechnology, Inc. | MAIA | โโ% | $79M | -1.4x |
| Mustang Bio, Inc. | MBIO | โโ% | $6M | -0.1x |
| Moleculin Biotech, Inc. | MBRX | โโ% | $12M | -2.3x |
| Mbx Biosciences, Inc. | MBX | โโ% | $1.21B | -x |
| Seres Therapeutics, Inc. | MCRB | โโ% | $84M | 14.8x |
| Medicus Pharma Ltd. | MDCX | โโ% | $12M | -x |
| Medicus Pharma Ltd. | MDCXW | โโ% | $52M | -x |
| Madrigal Pharmaceuticals, Inc. | MDGL | โโ% | $11.54B | -5.7x |
| Chrome Holding Co. | MEHCQ | โโ% | $96M | -x |
| Macrogenics Inc | MGNX | โโ% | $173M | -2.1x |
| Mira Pharmaceuticals, Inc. | MIRA | โโ% | $40M | -1.6x |
| Mirum Pharmaceuticals, Inc. | MIRM | โโ% | $5.57B | -20.0x |
| Milestone Pharmaceuticals Inc. | MIST | โโ% | $107M | -2.0x |
| Moonlake Immunotherapeutics | MLTX | โโ% | $1.21B | -50.8x |
| Mineralys Therapeutics, Inc. | MLYS | โโ% | $1.92B | -4.5x |
| Mannkind Corp | MNKD | โโ% | $730M | 124.4x |
| Medicinova Inc | MNOV | โโ% | $71M | -7.1x |
| Monopar Therapeutics | MNPR | โโ% | $357M | -3.0x |
| Mereo Biopharma Group โฆ | MREO | โโ% | $50M | -x |
| Merck & Co., โฆ | MRK | โโ% | $300.97B | 16.5x |
| Marker Therapeutics, Inc. | MRKR | โโ% | $21M | -0.6x |
| Mersana Therapeutics, Inc. | MRSN | โโ% | $145M | -3.4x |
| Merus N.V. | MRUS | โโ% | $6.83B | -13.5x |
| Maravai Lifesciences Holdings, โฆ | MRVI | โโ% | $1.13B | -5.6x |
| Matinas Biopharma Holdings, โฆ | MTNB | โโ% | $4M | -1.7x |
| Metsera, Inc. | MTSR | โโ% | $7.41B | -x |
| Metavia Inc. | MTVA | โโ% | $6M | -0.5x |
| Mural Oncology Plc | MURA | โโ% | $35M | -x |
| Mainz Biomed N.V. | MYNZ | โโ% | $7M | -x |
| Newamsterdam Pharma Co โฆ | NAMS | โโ% | $3.43B | -x |
| Newamsterdam Pharma Co โฆ | NAMSW | โโ% | $2.59B | -x |
| Natures Sunshine Products โฆ | NATR | โโ% | $417M | 21.4x |
| Nanobiotix S.A. | NBTX | โโ% | $1.49B | -x |
| Novabay Pharmaceuticals, Inc. | NBY | โโ% | $38M | 8.0x |
| Nucana Plc | NCNA | โโ% | $6M | -x |
| Minerva Neurosciences, Inc. | NERV | โโ% | $340M | -0.8x |
| Neuphoria Therapeutics Inc. | NEUP | โโ% | $21M | -x |
| Neurogene Inc. | NGNE | โโ% | $299M | -7.3x |
| Nika Pharmaceuticals, Inc | NIKA | โโ% | $786M | -x |
| Nektar Therapeutics | NKTR | โโ% | $1.87B | -1.2x |
| Nkarta, Inc. | NKTX | โโ% | $142M | -1.3x |
| Newcelx Ltd. | NLSP | โโ% | $54M | -x |
| Newcelx Ltd. | NLSPW | โโ% | $120K | -x |
| Nanoviricides, Inc. | NNVC | โโ% | $20M | -2.1x |
| Nurix Therapeutics, Inc. | NRIX | โโ% | $1.47B | -7.4x |
| Neurosense Therapeutics Ltd. | NRSN | โโ% | $25M | -x |
| Nrx Pharmaceuticals, Inc. | NRXP | โโ% | $66M | -0.6x |
| Neonc Technologies Holdings, โฆ | NTHI | โโ% | $172M | -x |
| Nuvation Bio Inc. | NUVB | โโ% | $1.37B | -1.2x |
| Nuvalent, Inc. | NUVL | โโ% | $6.99B | -30.9x |
| Nuvectis Pharma, Inc. | NVCT | โโ% | $192M | -3.9x |
| Novartis Ag | NVS | โโ% | $283.57B | -x |
| Northwest Biotherapeutics Inc | NWBO | โโ% | $319M | -x |
| Nexien Biopharma, Inc. | NXEN | โโ% | $10K | -x |
| Nextcure, Inc. | NXTC | โโ% | $35M | -0.5x |
| Ocean Biomedical, Inc. | OCEA | โโ% | $190K | -0.3x |
| Ocular Therapeutix, Inc | OCUL | โโ% | $1.82B | -8.2x |
| Oragenics Inc | OGEN | โโ% | $2M | -0.1x |
| Organigram Global Inc. | OGI | โโ% | $192M | -x |
| Organon & Co. | OGN | โโ% | $1.48B | 7.9x |
| Onkure Therapeutics, Inc. | OKUR | โโ% | $56M | -6.9x |
| Olema Pharmaceuticals, Inc. | OLMA | โโ% | $1.21B | -4.0x |
| Omeros Corp | OMER | โโ% | $757M | -4.2x |
| Beone Medicines Ltd. | ONC | โโ% | $34.11B | 118.9x |
| Onconetix, Inc. | ONCO | โโ% | $1M | -0.3x |
| Oncolytics Biotech Inc | ONCY | โโ% | $103M | -x |
| Opko Health, Inc. | OPK | โโ% | $826M | -3.5x |
| Organogenesis Holdings Inc. | ORGO | โโ% | $291M | 7.9x |
| Orgenesis Inc. | ORGS | โโ% | $3M | 0.9x |
| Oric Pharmaceuticals, Inc. | ORIC | โโ% | $1.42B | -4.2x |
| Oruka Therapeutics, Inc. | ORKA | โโ% | $2.22B | -x |
| Oramed Pharmaceuticals Inc. | ORMP | โโ% | $129M | 2.0x |
| Os Therapies Inc | OSTX | โโ% | $48M | -x |
| Oncotelic Therapeutics, Inc. | OTLC | โโ% | $18M | -x |
| Ovid Therapeutics Inc. | OVID | โโ% | $367M | -2.6x |
| One World Products, โฆ | OWPC | โโ% | $900K | -x |
| Phibro Animal Health โฆ | PAHC | โโ% | $2.16B | 23.5x |
| Prestige Consumer Healthcare โฆ | PBH | โโ% | $3.01B | 16.1x |
| Psyence Biomedical Ltd. | PBM | โโ% | $6M | -x |
| Puma Biotechnology, Inc. | PBYI | โโ% | $323M | 10.4x |
| Pacira Biosciences, Inc. | PCRX | โโ% | $929M | 132.1x |
| Processa Pharmaceuticals, Inc. | PCSA | โโ% | $6M | -0.5x |
| Procyon Corp | PCYN | โโ% | $980K | -x |
| Pds Biotechnology Corp | PDSB | โโ% | $33M | -1.7x |
| Pepgen Inc. | PEPG | โโ% | $119M | -1.6x |
| Pfizer Inc | PFE | โโ% | $159.38B | 20.5x |
| Precigen, Inc. | PGEN | โโ% | $1.15B | -1.4x |
| Phathom Pharmaceuticals, Inc. | PHAT | โโ% | $793M | -1.6x |
| Phio Pharmaceuticals Corp. | PHIO | โโ% | $14M | -0.8x |
| Pharvaris N.V. | PHVS | โโ% | $1.71B | -x |
| Protokinetix, Inc. | PKTX | โโ% | $2M | -x |
| Plandai Biotechnology, Inc. | PLPL | โโ% | $4M | -x |
| Pliant Therapeutics, Inc. | PLRX | โโ% | $82M | -4.5x |
| Polomar Health Services, โฆ | PMHS | โโ% | $4M | -x |
| Promis Neurosciences Inc. | PMN | โโ% | $157M | -2.1x |
| Pmv Pharmaceuticals, Inc. | PMVP | โโ% | $66M | -1.6x |
| Purple Biotech Ltd. | PPBT | โโ% | $6M | -x |
| Propanc Biopharma, Inc. | PPCB | โโ% | $2M | -x |
| Praxis Precision Medicines, โฆ | PRAX | โโ% | $7.71B | -4.0x |
| Prf Technologies Ltd. | PRFX | โโ% | $2M | -x |
| Perrigo Co Plc | PRGO | โโ% | $1.35B | -27.6x |
| Prelude Therapeutics Inc | PRLD | โโ% | $214M | -0.5x |
| Prophase Labs, Inc. | PRPH | โโ% | $360K | -0.5x |
| Proqr Therapeutics N.V. | PRQR | โโ% | $169M | -x |
| Prothena Corp Public โฆ | PRTA | โโ% | $462M | -12.4x |
| Ptc Therapeutics, Inc. | PTCT | โโ% | $5.55B | 8.1x |
| Protagonist Therapeutics, Inc | PTGX | โโ% | $5.99B | 119.5x |
| Protagenic Therapeutics, Inc.\New | PTIX | โโ% | $1M | -2.8x |
| Palatin Technologies Inc | PTNT | โโ% | $17M | -x |
| Petros Pharmaceuticals, Inc. | PTPI | โโ% | $230K | -0.1x |
| Pulmatrix, Inc. | PULM | โโ% | $5M | -1.8x |
| Provectus Biopharmaceuticals, Inc. | PVCT | โโ% | $21M | -x |
| Palvella Therapeutics, Inc. | PVLA | โโ% | $1.66B | -x |
| Pyxis Oncology, Inc. | PYXS | โโ% | $87M | -1.3x |
| Aixcrypto Holdings, Inc. | QLGN | โโ% | $8M | -1.3x |
| Quoin Pharmaceuticals, Ltd. | QNRX | โโ% | $10M | -x |
| Quantum Biopharma Ltd. | QNTM | โโ% | $21M | -x |
| Q32 Bio Inc. | QTTB | โโ% | $92M | 3.1x |
| Uniqure N.V. | QURE | โโ% | $986M | -2.8x |
| Radiopharm Theranostics Ltd | RADX | โโ% | $34M | -x |
| Rani Therapeutics Holdings, โฆ | RANI | โโ% | $78M | -1.3x |
| Rapport Therapeutics, Inc. | RAPP | โโ% | $1.40B | -x |
| Rapt Therapeutics, Inc. | RAPT | โโ% | $1.56B | -0.4x |
| Ultragenyx Pharmaceutical Inc. | RARE | โโ% | $2.00B | -7.0x |
| Rocket Pharmaceuticals, Inc. | RCKT | โโ% | $489M | -4.8x |
| Arcus Biosciences, Inc. | RCUS | โโ% | $2.73B | -5.5x |
| Dr Reddys Laboratories โฆ | RDY | โโ% | $11.52B | -x |
| Regeneron Pharmaceuticals, Inc. | REGN | โโ% | $80.56B | 17.9x |
| Revelation Biosciences, Inc. | REVB | โโ% | $5M | -0.1x |
| Rafael Holdings, Inc. | RFL | โโ% | $62M | -0.9x |
| Regen Biopharma Inc | RGBP | โโ% | $130K | -x |
| Regen Biopharma Inc | RGBPP | โโ% | $470K | -x |
| Rigel Pharmaceuticals Inc | RIGL | โโ% | $488M | 1.3x |
| Relmada Therapeutics, Inc. | RLMD | โโ% | $730M | -0.1x |
| Rallybio Corp | RLYB | โโ% | $53M | -0.7x |
| Retrieve Medical Holdings, โฆ | RMHI | โโ% | $26M | -x |
| Rockwell Medical, Inc. | RMTI | โโ% | $34M | -17.1x |
| Avidity Biosciences, Inc. | RNA | โโ% | $206M | -12.2x |
| Cartesian Therapeutics, Inc. | RNAC | โโ% | $164M | -2.1x |
| Transcode Therapeutics, Inc. | RNAZ | โโ% | $7M | -0.2x |
| Rein Therapeutics, Inc. | RNTX | โโ% | $35M | -x |
| Renovorx, Inc. | RNXT | โโ% | $48M | -3.4x |
| Roivant Sciences Ltd. | ROIV | โโ% | $19.66B | 1.8x |
| Royalty Pharma Plc | RPRX | โโ% | $27.43B | 35.6x |
| Repare Therapeutics Inc. | RPTX | โโ% | $114M | -2.1x |
| Rest Ez Inc. | RTEZ | โโ% | $1.93B | -x |
| Rapid Therapeutic Science โฆ | RTSL | โโ% | $110K | 1.9x |
| Reviva Pharmaceuticals Holdings, โฆ | RVPH | โโ% | $12M | -4.1x |
| Rhythm Pharmaceuticals, Inc. | RYTM | โโ% | $5.70B | -20.3x |
| Rezolute, Inc. | RZLT | โโ% | $233M | -3.9x |
| Filana Therapeutics, Inc. | SAVA | โโ% | $101M | -1.9x |
| Sunshine Biopharma Inc. | SBFM | โโ% | $5M | -0.6x |
| Scienture Holdings, Inc. | SCNX | โโ% | $12M | 2.9x |
| Scpharmaceuticals Inc. | SCPH | โโ% | $302M | -2.0x |
| Scorpius Holdings, Inc. | SCPX | โโ% | $790K | 0.0x |
| Scynexis Inc | SCYX | โโ% | $40M | -2.4x |
| Schrodinger, Inc. | SDGR | โโ% | $834M | -7.8x |
| Septerna, Inc. | SEPN | โโ% | $1.10B | -x |
| Serina Therapeutics, Inc. | SER | โโ% | $26M | 22.6x |
| Sagimet Biosciences Inc. | SGMT | โโ% | $152M | -x |
| Shuttle Pharmaceuticals Holdings, โฆ | SHPH | โโ% | $3M | -x |
| Siga Technologies Inc | SIGA | โโ% | $377M | 16.2x |
| Silo Pharma, Inc. | SILO | โโ% | $5M | -x |
| Sionna Therapeutics, Inc. | SION | โโ% | $1.69B | -x |
| Skinvisible, Inc. | SKVI | โโ% | $2M | -x |
| Skye Bioscience, Inc. | SKYE | โโ% | $21M | -0.7x |
| Sol-Gel Technologies Ltd. | SLGL | โโ% | $242M | -x |
| Silence Therapeutics Plc | SLN | โโ% | $244M | -x |
| Silence Therapeutics Plc | SLNCF | โโ% | $213M | -x |
| Soleno Therapeutics Inc | SLNO | โโ% | $1.75B | 83.8x |
| Salarius Pharmaceuticals, Inc. | SLRX | โโ% | $2M | -0.5x |
| Sellas Life Sciences โฆ | SLS | โโ% | $739M | -1.0x |
| Summit Therapeutics Inc. | SMMT | โโ% | $14.05B | 104.1x |
| Syndax Pharmaceuticals Inc | SNDX | โโ% | $2.10B | -4.1x |
| Soligenix, Inc. | SNGX | โโ% | $12M | -1.8x |
| Sibannac, Inc. | SNNC | โโ% | $940K | -x |
| Sensei Biotherapeutics, Inc. | SNSE | โโ% | $34M | -0.4x |
| Sanofi | SNY | โโ% | $116.96B | -x |
| Sonnet Biotherapeutics Holdings, โฆ | SONN | โโ% | $4M | -1.6x |
| Spruce Biosciences, Inc. | SPRB | โโ% | $90M | -0.4x |
| Scisparc Ltd. | SPRC | โโ% | $2M | -x |
| Spero Therapeutics, Inc. | SPRO | โโ% | $130M | 15.2x |
| Ars Pharmaceuticals, Inc. | SPRY | โโ% | $780M | -23.5x |
| Sarepta Therapeutics, Inc. | SRPT | โโ% | $2.31B | 162.5x |
| Stoke Therapeutics, Inc. | STOK | โโ% | $1.96B | 45.5x |
| Shattuck Labs, Inc. | STTK | โโ% | $449M | -x |
| Supernus Pharmaceuticals, Inc. | SUPN | โโ% | $2.85B | 46.0x |
| Savara Inc | SVRA | โโ% | $1.12B | -8.2x |
| 60 Degrees Pharmaceuticals, โฆ | SXTP | โโ% | $4M | -0.6x |
| Synlogic, Inc. | SYBX | โโ% | $8M | 3.6x |
| Spyre Therapeutics, Inc. | SYRE | โโ% | $3.92B | -0.7x |
| Syros Pharmaceuticals, Inc. | SYRS | โโ% | $20K | -0.1x |
| Takeda Pharmaceutical Co โฆ | TAK | โโ% | $58.51B | -x |
| Theravance Biopharma, Inc. | TBPH | โโ% | $821M | 7.8x |
| Alaunos Therapeutics, Inc. | TCRT | โโ% | $6M | -1.0x |
| Telomir Pharmaceuticals, Inc. | TELO | โโ% | $44M | -x |
| Tenax Therapeutics, Inc. | TENX | โโ% | $237M | -14.9x |
| Terns Pharmaceuticals, Inc. | TERN | โโ% | $5.92B | -5.1x |
| Teva Pharmaceutical Industries โฆ | TEVA | โโ% | $33.70B | 23.9x |
| Teva Pharmaceutical Industries โฆ | TEVJF | โโ% | $38.09B | 53.4x |
| Tg Therapeutics, Inc. | TGTX | โโ% | $5.21B | 11.6x |
| Canton Strategic Holdings, โฆ | THAR | โโ% | $186M | -x |
| Talphera, Inc. | TLPH | โโ% | $37M | -2.3x |
| Telix Pharmaceuticals Ltd | TLX | โโ% | $3.24B | -x |
| Tango Therapeutics, Inc. | TNGX | โโ% | $2.81B | -2.8x |
| Tonix Pharmaceuticals Holding โฆ | TNXP | โโ% | $174M | 0.0x |
| Theriva Biologics, Inc. | TOVX | โโ% | $9M | -0.4x |
| Tempest Therapeutics, Inc. | TPST | โโ% | $22M | -0.5x |
| Traws Pharma, Inc. | TRAW | โโ% | $17M | -0.6x |
| Entrada Therapeutics, Inc. | TRDA | โโ% | $473M | 6.9x |
| Trevi Therapeutics, Inc. | TRVI | โโ% | $1.44B | -6.1x |
| Trevena Inc | TRVN | โโ% | $260K | -1.3x |
| Tvardi Therapeutics, Inc. | TVRD | โโ% | $30M | -x |
| Travere Therapeutics, Inc. | TVTX | โโ% | $2.66B | -x |
| Therapeuticsmd, Inc. | TXMD | โโ% | $27M | 538.2x |
| Tyra Biosciences, Inc. | TYRA | โโ% | $1.99B | -9.5x |
| Unicycive Therapeutics, Inc. | UNCY | โโ% | $166M | -0.9x |
| Upstream Bio, Inc. | UPB | โโ% | $468M | -x |
| Urogen Pharma Ltd. | URGN | โโ% | $894M | -2.5x |
| United Therapeutics Corp | UTHR | โโ% | $25.57B | 19.2x |
| Vaccinex, Inc. | VCNX | โโ% | $3M | -0.1x |
| Vera Therapeutics, Inc. | VERA | โโ% | $2.52B | -20.4x |
| Veru Inc. | VERU | โโ% | $39M | -0.8x |
| Vicapsys Life Sciences, โฆ | VICP | โโ% | $47M | -x |
| Vincerx Pharma, Inc. | VINC | โโ% | $70K | -0.2x |
| Viracta Therapeutics, Inc. | VIRX | โโ% | $390K | -0.2x |
| Viking Therapeutics, Inc. | VKTX | โโ% | $3.75B | -67.5x |
| Vanda Pharmaceuticals Inc. | VNDA | โโ% | $401M | -16.1x |
| Verrica Pharmaceuticals Inc. | VRCA | โโ% | $89M | -0.5x |
| Viridian Therapeutics, Inc.\De | VRDN | โโ% | $2.89B | -4.5x |
| Vireo Growth Inc. | VREOF | โโ% | $348M | -x |
| Verona Pharma Plc | VRNA | โโ% | $73.55B | -185.1x |
| Virpax Pharmaceuticals, Inc. | VRPX | โโ% | $160K | 0.0x |
| Vertex Pharmaceuticals Inc โฆ | VRTX | โโ% | $113.42B | 28.7x |
| Verastem, Inc. | VSTM | โโ% | $447M | -6.5x |
| Vistagen Therapeutics, Inc. | VTGN | โโ% | $21M | -0.1x |
| Viatris Inc | VTRS | โโ% | $15.79B | -29.5x |
| Vtv Therapeutics Inc. | VTVT | โโ% | $0.00M | -3.3x |
| Ventyx Biosciences, Inc. | VTYX | โโ% | $999M | -1.0x |
| Vyne Therapeutics Inc. | VYNE | โโ% | $20M | -0.4x |
| Whitehawk Therapeutics, Inc. | WHWK | โโ% | $161M | -x |
| Wave Life Sciences โฆ | WVE | โโ% | $1.36B | -22.2x |
| Xenetic Biosciences, Inc. | XBIO | โโ% | $6M | -x |
| Xbiotech Inc. | XBIT | โโ% | $72M | -3.5x |
| Exicure, Inc. | XCUR | โโ% | $27M | -1.9x |
| Xenon Pharmaceuticals Inc. | XENE | โโ% | $5.55B | -15.4x |
| Xeris Biopharma Holdings, โฆ | XERS | โโ% | $964M | 1740.2x |
| Xilio Therapeutics, Inc. | XLO | โโ% | $618M | -0.5x |
| Xencor Inc | XNCR | โโ% | $891M | -8.4x |
| Xoma Royalty Corp | XOMA | โโ% | $372M | 11.7x |
| Xoma Royalty Corp | XOMAO | โโ% | $312M | 14.4x |
| Xoma Royalty Corp | XOMAP | โโ% | $326M | 15.1x |
| Xtl Biopharmaceuticals Ltd | XTLB | โโ% | $26M | -x |
| Zenas Biopharma, Inc. | ZBIO | โโ% | $1.07B | -x |
| Zai Lab Ltd | ZLAB | โโ% | $2.12B | -95.2x |
| Zentalis Pharmaceuticals, Inc. | ZNTL | โโ% | $162M | -1.4x |
| Zomedica Corp. | ZOMDF | โโ% | $132M | -x |
| Zoetis Inc. | ZTS | โโ% | $50.20B | 18.8x |
| Zevra Therapeutics, Inc. | ZVRA | โโ% | $530M | 6.4x |
| Zyversa Therapeutics, Inc. | ZVSA | โโ% | $2M | -x |
| Zymeworks Inc. | ZYME | โโ% | $1.75B | -8.3x |
FAQ
-
Is Corbus Pharmaceuticals Holdings, Inc. a good stock to buy?
Our AI analyzes Corbus Pharmaceuticals Holdings, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.
-
How accurate are Corbus Pharmaceuticals Holdings, Inc. predictions?
Our AI achieves a -5% Spearman correlation for this stock, with 67%+ average accuracy across 4,000+ stocks analyzed daily.
-
How often are forecasts updated?
Corbus Pharmaceuticals Holdings, Inc. forecasts are updated daily using the latest market data and AI models.
Ready to invest smarter?
Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Corbus Pharmaceuticals Holdings, Inc.?
View full institutional-grade analysis on Intratio โAI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.